Roles Nrf2 plays in myeloid cells and related disorders

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Kobayashi, Eri ^a   Suzuki, Takafumi ^a   Yamamoto, Masayuki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATION; ANTIOXIDATIVE; ANTITUMOR IMMUNITY; BACTERICIDAL ACTIVITY; PRIMARY FUNCTIONS; PROTEASOMAL DEGRADATION; REACTIVE OXYGEN SPECIES; ROS GENERATIONS;

ANTIGEN-ANTIBODY REACTIONS; BACTERICIDES; CELL DEATH; CHEMICAL COMPOUNDS; DISEASES; GENES; PATHOLOGY; SENSORS; TRANSCRIPTION; TRANSCRIPTION FACTORS;

DETOXIFICATION;

8 NITROGUANOSINE 3',5' CYCLICMONOPHOSPHATE; APOLIPOPROTEIN E; CD11B ANTIGEN; CD36 ANTIGEN; CIGARETTE SMOKE; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; ELECTROPHILE; ENDOTOXIN; GLUCOSE; GUANOSINE PHOSPHATE; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1BETA; KELCH LIKE ECH ASSOCIATED PROTEIN 1; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; NITRIC OXIDE; NITROGEN DIOXIDE; OMEGA 3 FATTY ACID; PROSTAGLANDIN A2; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER RECEPTOR A; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR NRF2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ATHEROGENESIS; ATHEROSCLEROSIS; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROTECTION; CELL SURVIVAL; CYTOTOXICITY; DETOXIFICATION; DISEASE SEVERITY; DISEASES; DOWN REGULATION; EMPHYSEMA; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LEWIS CARCINOMA; MACROPHAGE; MELANOMA; METASTASIS; MOLECULE; NEUTROPHIL; NITRATION; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTE; PHAGOCYTOSIS; PNEUMONIA; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TUMOR CELL; TUMOR IMMUNITY; UBIQUITINATION; UPREGULATION; ANIMAL; IMMUNITY; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALIA;

ANIMALS; DISEASE; HUMANS; IMMUNITY; INFLAMMATION; MYELOID CELLS; NF-E2-RELATED FACTOR 2; PHAGOCYTOSIS;

EID: 84879344989     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/529219     Document Type: Review

References (67)

1. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. I., An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochemical and Biophysical Research Communications 1997 236 2 313 322 2-s2.0-0031577292 10.1006/bbrc.1997.6943
2. Taguchi K., Motohashi H., Yamamoto M., Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes to Cells 2011 16 2 123 140
3. Itoh K., Wakabayashi N., Katoh Y., Ishii T., O'Connor T., Yamamoto M., Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes to Cells 2003 8 4 379 391 2-s2.0-12444257799 10.1046/j.1365-2443.2003.00640.x
4. McMahon M., Itoh K., Yamamoto M., Hayes J. D., Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. The Journal of Biological Chemistry 2003 278 24 21592 21600 2-s2.0-0037821802 10.1074/jbc.M300931200
5. Kobayashi A., Kang M. I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., Yamamoto M., Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Molecular and Cellular Biology 2004 24 16 7130 7139 2-s2.0-3543008924 10.1128/MCB.24.16. 7130-7139.2004
6. Kobayashi A., Kang M. I., Watai Y., Tong K. I., Shibata T., Uchida K., Yamamoto M., Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Molecular and Cellular Biology 2006 26 1 221 229 2-s2.0-33344469643 10.1128/MCB.26.1.221-229.2006
7. Friling R. S., Bensimon A., Tichauer Y., Daniel V., Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proceedings of the National Academy of Sciences of the United States of America 1990 87 16 6258 6262 2-s2.0-0025145723 10.1073/pnas.87.16.6258
8. Rushmore T. H., Morton M. R., Pickett C. B., The antioxidant responsive element: activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. The Journal of Biological Chemistry 1991 266 18 11632 11639 2-s2.0-0025948113
9. Kobayashi M., Yamamoto M., Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxidants and Redox Signaling 2005 7 3-4 385 394 2-s2.0-14044254798 10.1089/ars.2005.7.385
10. Dinkova-Kostova A. T., Holtzclaw W. D., Cole R. N., Itoh K., Wakabayashi N., Katoh Y., Yamamoto M., Talalay P., Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proceedings of the National Academy of Sciences of the United States of America 2002 99 18 11908 11913 2-s2.0-0037015035 10.1073/pnas.172398899
11. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J. D., Yamamoto M., Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes and Development 1999 13 1 76 86 2-s2.0-0032953192
12. Zhang D. D., Lo S. C., Cross J. V., Templeton D. J., Hannink M., Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Molecular and Cellular Biology 2004 24 24 10941 10953 2-s2.0-10044228504 10.1128/MCB.24.24.10941-10953.2004
13. Holtzclaw W. D., Dinkova-Kostova A. T., Talalay P., Protection against electrophile and oxidative stress by induction of phase 2 genes: the quest for the elusive sensor that responds to inducers. Advances in Enzyme Regulation 2004 44 1 335 367 2-s2.0-9644272830 10.1016/j.advenzreg.2003.11.013
14. Itoh K., Mochizuki M., Ishii Y., Ishii T., Shibata T., Kawamoto Y., Kelly V., Sekizawa K., Uchida K., Yamamoto M., Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Δ12, 14-prostaglandin J2 Molecular and Cellular Biology 2004 24 1 36 45 2-s2.0-10744230015 10.1128/MCB.24.1.36-45.2004
15. McMahon M., Lamont D. J., Beattie K. A., Hayes J. D., Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proceedings of the National Academy of Sciences of the United States of America 2010 107 44 18838 18843 2-s2.0-78650509515 10.1073/pnas.1007387107
16. Um H. C., Jang J. H., Kim D. H., Nitric oxide activates Nrf2 through S-nitrosylation of Keap1 in PC12 cells. Nitric Oxide 2011 25 2 161 168
17. Sawa T., Zaki M. H., Okamoto T., Akuta T., Tokutomi Y., Kim-Mitsuyama S., Ihara H., Kobayashi A., Yamamoto M., Fujii S., Arimoto H., Akaike T., Protein S-guanylation by the biological signal 8-nitroguanosine 3',5'-cyclic monophosphate. Nature Chemical Biology 2007 3 11 727 735 2-s2.0-35348941210 10.1038/nchembio.2007.33
18. Fujii S., Sawa T., Ihara H., Tong K. I., Ida T., Okamoto T., Ahtesham A. K., Ishima Y., Motohashi H., Yamamoto M., Akaike T., The critical role of nitric oxide signaling, via protein S-guanylation and nitrated cyclic GMP, in the antioxidant adaptive response. The Journal of Biological Chemistry 2010 285 31 23970 23984 2-s2.0-77954947797 10.1074/jbc.M110.145441
19. Tsujita T., Li L., Nakajima H., Iwamoto N., Nakajima-Takagi Y., Ohashi K., Kawakami K., Kumagai Y., Freeman B. A., Yamamoto M., Kobayashi M., Nitro-fatty acids and cyclopentenone prostaglandins share strategies to activate the Keap1-Nrf2 system: a study using green fluorescent protein transgenic zebrafish. Genes to Cells 2011 16 1 46 57 2-s2.0-78650662928 10.1111/j.1365-2443.2010.01466.x
20. Kansanen E., Bonacci G., Schopfer F. J., Kuosmanen S. M., Tong K. I., Leinonen H., Woodcock S. R., Yamamoto M., Carlberg C., Ylä-Herttuala S., Freeman B. A., Levonen A. L., Electrophilic nitro-fatty acids activate Nrf2 by a Keap1 cysteine 151-independent mechanism. The Journal of Biological Chemistry 2011 286 16 14019 14027 2-s2.0-79954616432 10.1074/jbc.M110.190710
21. Ishii T., Itoh K., Takahashi S., Sato H., Yanagawa T., Katoh Y., Bannai S., Yamamoto M., Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. The Journal of Biological Chemistry 2000 275 21 16023 16029 2-s2.0-0034717329 10.1074/jbc.275.21.16023
22. Kwak M. K., Wakabayashi N., Itoh K., Motohashi H., Yamamoto M., Kensler T. W., Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway: identification of novel gene clusters for cell survival. The Journal of Biological Chemistry 2003 278 10 8135 8145 2-s2.0-0037424262 10.1074/jbc.M211898200
23. Hayes J. D., Chanas S. A., Henderson C. J., McMahon M., Sun C., Moffat G. J., Wolf C. R., Yamamoto M., The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochemical Society Transactions 2000 28 2 33 41 2-s2.0-0033956744
24. Banning A., Deubel S., Kluth D., Zhou Z., Brigelius-Flohé R., The GI-GPx gene is a target for Nrf2. Molecular and Cellular Biology 2005 25 12 4914 4923 2-s2.0-20344405468 10.1128/MCB.25.12.4914-4923.2005
25. Wild A. C., Moinova H. R., Mulcahy R. T., Regulation of γ -glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. The Journal of Biological Chemistry 1999 274 47 33627 33636 2-s2.0-0033584867 10.1074/jbc.274.47.33627
26. Alam J., Stewart D., Touchard C., Boinapally S., Choi A. M. K., Cook J. L., Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. The Journal of Biological Chemistry 1999 274 37 26071 26078 2-s2.0-0033543566 10.1074/jbc.274.37.26071
27. Aoki Y., Sato H., Nishimura N., Takahashi S., Itoh K., Yamamoto M., Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicology and Applied Pharmacology 2001 173 3 154 160 2-s2.0-0035875447 10.1006/taap.2001.9176
28. Enomoto A., Itoh K., Nagayoshi E., Haruta J., Kimura T., O'Connor T., Harada T., Yamamoto M., High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicological Sciences 2001 59 1 169 177 2-s2.0-0035153227 10.1093/toxsci/59.1.169
29. Mitsuishi Y., Taguchi K., Kawatani Y., Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 2012 22 1 66 79
30. Komatsu M., Kurokawa H., Waguri S., Taguchi K., Kobayashi A., Ichimura Y., Sou Y. S., Ueno I., Sakamoto A., Tong K. I., Kim M., Nishito Y., Iemura S. I., Natsume T., Ueno T., Kominami E., Motohashi H., Tanaka K., Yamamoto M., The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nature Cell Biology 2010 12 3 213 223 2-s2.0-77649265091 10.1038/ncb2021
31. Jain A., Lamark T., Sjøttem E., Larsen K. B., Awuh J. A., Øvervatn A., McMahon M., Hayes J. D., Johansen T., p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. The Journal of Biological Chemistry 2010 285 29 22576 22591 2-s2.0-77954599053 10.1074/jbc.M110.118976
32. Hoetzenecker W., Echtenacher B., Guenova E., ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nature Medicine 2011 18 1 128 134
33. Kobayashi M., Li L., Iwamoto N., Nakajima-Takagi Y., Kaneko H., Nakayama Y., Eguchi M., Wada Y., Kumagai Y., Yamamoto M., The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Molecular and Cellular Biology 2009 29 2 493 502 2-s2.0-58249117780 10.1128/MCB.01080-08
34. Takaya K., Suzuki T., Motohashi H., Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. Free Radical Biology and Medicine 2012 53 4 817 827
35. Groeger A. L., Cipollina C., Cole M. P., Woodcock S. R., Bonacci G., Rudolph T. K., Rudolph V., Freeman B. A., Schopfer F. J., Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nature Chemical Biology 2010 6 6 433 441 2-s2.0-77952487662 10.1038/nchembio.367
36. Schreck R., Rieber P., Baeuerle P. A., Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF- B transcription factor and HIV-1. The EMBO Journal 1991 10 8 2247 2258 2-s2.0-0025739254
37. Gloire G., Legrand-Poels S., Piette J., NF- B activation by reactive oxygen species: fifteen years later. Biochemical Pharmacology 2006 72 11 1493 1505 2-s2.0-33750523632 10.1016/j.bcp.2006.04.011
38. Powers K. A., Szászi K., Khadaroo R. G., Tawadros P. S., Marshall J. C., Kapus A., Rotstein O. D., Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. Journal of Experimental Medicine 2006 203 8 1951 1961 2-s2.0-33746890826 10.1084/jem.20060943
39. Nakahira K., Kim H. P., Geng X. H., Nakao A., Wang X., Murase N., Drain P. F., Wang X., Sasidhar M., Nabel E. G., Takahashi T., Lukacs N. W., Ryter S. W., Morita K., Choi A. M. K., Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. Journal of Experimental Medicine 2006 203 10 2377 2389 2-s2.0-33749322644 10.1084/jem.20060845
40. Kong X., Thimmulappa R., Kombairaju P., Biswal S., NADPH oxidase-dependent reactive oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-deficient mice. Journal of Immunology 2010 185 1 569 577 2-s2.0-77956193657 10.4049/jimmunol.0902315
41. Kong X., Thimmulappa R., Craciun F., Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis. American Journal of Respiratory and Critical Care Medicine 2011 184 8 928 938
42. Harvey C. J., Thimmulappa R. K., Sethi S., Kong X., Yarmus L., Brown R. H., Feller-Kopman D., Wise R., Biswal S., Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Science Translational Medicine 2011 3 78 2-s2.0-79954542852 10.1126/scitranslmed.3002042 78ra32
43. Hou Y., Xue P., Bai Y., Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of CCAAT/enhancer-binding protein β during adipogenesis. Free Radical Biology and Medicine 2012 52 2 462 472
44. Huber R., Pietsch D., Panterodt T., Brand K., Regulation of C/EBP β and resulting functions in cells of the monocytic lineage. Cellular Signaling 2012 24 6 1287 1296
45. Iizuka T., Ishii Y., Itoh K., Kiwamoto T., Kimura T., Matsuno Y., Morishima Y., Hegab A. E., Homma S., Nomura A., Sakamoto T., Shimura M., Yoshida A., Yamamoto M., Sekizawa K., Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes to Cells 2005 10 12 1113 1125 2-s2.0-29244473882 10.1111/j.1365-2443.2005.00905.x
46. Cho H. Y., Jedlicka A. E., Reddy S. P. M., Kensler T. W., Yamamoto M., Zhang L. Y., Kleeberger S. R., Role of NRF2 in protection against hyperoxic lung injury in mice. American Journal of Respiratory Cell and Molecular Biology 2002 26 2 175 182 2-s2.0-0036007313
47. Reddy N. M., Kleeberger S. R., Kensler T. W., Yamamoto M., Hassoun P. M., Reddy S. P., Disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice. Journal of Immunology 2009 182 11 7264 7271 2-s2.0-67449168081 10.4049/jimmunol.0804248
48. Athale J., Ulrich A., MacGarvey N. C., Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice. Free Radical Biology and Medicine 2012 53 8 1584 1594
49. Rangasamy T., Guo J., Mitzner W. A., Roman J., Singh A., Fryer A. D., Yamamoto M., Kensler T. W., Tuder R. M., Georas S. N., Biswal S., Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. Journal of Experimental Medicine 2005 202 1 47 59 2-s2.0-22344438250 10.1084/jem.20050538
50. Thimmulappa R. K., Lee H., Rangasamy T., Reddy S. P., Yamamoto M., Kensler T. W., Biswal S., Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. Journal of Clinical Investigation 2006 116 4 984 995 2-s2.0-33645530745 10.1172/JCI25790
51. Ishii Y., Itoh K., Morishima Y., Kimura T., Kiwamoto T., Iizuka T., Hegab A. E., Hosoya T., Nomura A., Sakamoto T., Yamamoto M., Sekizawa K., Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. Journal of Immunology 2005 175 10 6968 6975 2-s2.0-27744450995
52. Satoh H., Moriguchi T., Taguchi K., Takai J., Maher J. M., Suzuki T., Winnard P. T., Raman V., Ebina M., Nukiwa T., Yamamoto M., Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung. Carcinogenesis 2010 31 10 1833 1843 2-s2.0-77957796093 10.1093/carcin/bgq105
53. Gabrilovich D. I., Nagaraj S., Myeloid-derived suppressor cells as regulators of the immune system. Nature Reviews Immunology 2009 9 3 162 174 2-s2.0-61349100687 10.1038/nri2506
54. Ramos-Gomez M., Kwak M. K., Dolan P. M., Itoh K., Yamamoto M., Talalay P., Kensler T. W., Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 2001 98 6 3410 3415 2-s2.0-0035853157 10.1073/pnas.051618798
55. Iida K., Itoh K., Kumagai Y., Oyasu R., Hattori K., Kawai K., Shimazui T., Akaza H., Yamamoto M., Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Research 2004 64 18 6424 6431 2-s2.0-4644328941 10.1158/0008-5472.CAN-04-1906
56. Ohkoshi A., Suzuki T., Ono M., Roles of Keap1-Nrf2 system in upper aerodigestive tract carcinogenesis. Cancer Prevention Research 2013 6 2 149 159
57. Shibata T., Ohta T., Tong K. I., Kokubu A., Odogawa R., Tsuta K., Asamura H., Yamamoto M., Hirohashi S., Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proceedings of the National Academy of Sciences of the United States of America 2008 105 36 13568 13573 2-s2.0-51649130168 10.1073/pnas.0806268105
58. Ohta T., Iijima K., Miyamoto M., Nakahara I., Tanaka H., Ohtsuji M., Suzuki T., Kobayashi A., Yokota J., Sakiyama T., Shibata T., Yamamoto M., Hirohashi S., Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Research 2008 68 5 1303 1309 2-s2.0-40449107193 10.1158/0008-5472.CAN-07-5003
59. Guichard C., Amaddeo G., Imbeaud S., Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nature Genetics 2012 44 6 694 698
60. Sussan T. E., Jun J., Thimmulappa R., Bedja D., Antero M., Gabrielson K. L., Polotsky V. Y., Biswal S., Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice. PLoS ONE 2008 3 11 2-s2.0-56849124834 10.1371/journal.pone.0003791 e3791
61. Barajas B., Che N., Yin F., Rowshanrad A., Orozco L. D., Gong K. W., Wang X., Castellani L. W., Reue K., Lusis A. J., Araujo J. A., NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 1 58 66 2-s2.0-78650913866 10.1161/ATVBAHA.110. 210906
62. Freigang S., Ampenberger F., Spohn G., Heer S., Shamshiev A. T., Kisielow J., Hersberger M., Yamamoto M., Bachmann M. F., Kopf M., Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. European Journal of Immunology 2011 41 7 2040 2051 2-s2.0-79959732295 10.1002/eji.201041316
63. Harada N., Ito K., Hosoya T., Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation. Free Radical Biology and Medicine 2012 53 12 2256 2262
64. Ishii T., Itoh K., Ruiz E., Leake D. S., Unoki H., Yamamoto M., Mann G. E., Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circulation Research 2004 94 5 609 616 2-s2.0-1642396537 10.1161/01.RES. 0000119171.44657.45
65. Maruyama A., Tsukamoto S., Nishikawa K., Yoshida A., Harada N., Motojima K., Ishii T., Nakane A., Yamamoto M., Itoh K., Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements. Archives of Biochemistry and Biophysics 2008 477 1 139 145 2-s2.0-48749091560 10.1016/j.abb.2008.06.004
66. Ruotsalainen A. K., Inkala M., Partanen M. E., The absence of macrophage Nrf2 promotes early atherogenesis. Cardiovascular Research 2013 98 1 107 115
67. Collins A. R., Gupte A. A., Ji R., Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 12 2839 2846